These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 34878454)
1. Li B; Zhang H; Shi L; Li R; Luo Y; Deng Y; Li S; Li R; Liu Z Food Funct; 2022 Jan; 13(1):102-112. PubMed ID: 34878454 [TBL] [Abstract][Full Text] [Related]
2. Intestinal anti-inflammatory effect of the probiotic Saccharomyces boulardii in DSS-induced colitis in mice: Impact on microRNAs expression and gut microbiota composition. Rodríguez-Nogales A; Algieri F; Garrido-Mesa J; Vezza T; Utrilla MP; Chueca N; García F; Rodríguez-Cabezas ME; Gálvez J J Nutr Biochem; 2018 Nov; 61():129-139. PubMed ID: 30236870 [TBL] [Abstract][Full Text] [Related]
3. Mechanism and therapeutic effects of Saccharomyces boulardii on experimental colitis in mice. Zhou H; Zhang HJ; Guan L; Zhang YN; Li Y; Sun MJ Mol Med Rep; 2018 Dec; 18(6):5652-5662. PubMed ID: 30387820 [TBL] [Abstract][Full Text] [Related]
5. Both Xu X; Wu J; Jin Y; Huang K; Zhang Y; Liang Z Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986214 [TBL] [Abstract][Full Text] [Related]
6. Saccharomyces boulardii alleviates ulcerative colitis carcinogenesis in mice by reducing TNF-α and IL-6 levels and functions and by rebalancing intestinal microbiota. Wang C; Li W; Wang H; Ma Y; Zhao X; Zhang X; Yang H; Qian J; Li J BMC Microbiol; 2019 Nov; 19(1):246. PubMed ID: 31694526 [TBL] [Abstract][Full Text] [Related]
7. Gao H; Li Y; Sun J; Xu H; Wang M; Zuo X; Fu Q; Guo Y; Chen Z; Zhang P; Li X; Wang N; Ye T; Yao Y Oxid Med Cell Longev; 2021; 2021():1622375. PubMed ID: 34367460 [No Abstract] [Full Text] [Related]
8. Saccharomyces boulardii (CNCM I-745) alleviates collagen-induced arthritis by partially maintaining intestinal mucosal integrity through TLR2/MYD88/NF-κB pathway inhibition. Ahmad ; Zhang C; Wang Y; Ullah H; Rahman AU; Wei J; Qin YH; Wang G; Wang B; Li X Int Immunopharmacol; 2024 Sep; 139():112738. PubMed ID: 39053232 [TBL] [Abstract][Full Text] [Related]
9. Treatment of murine colitis by Saccharomyces boulardii secreting atrial natriuretic peptide. Liu CH; Chang JH; Chang YC; Mou KY J Mol Med (Berl); 2020 Dec; 98(12):1675-1687. PubMed ID: 33025105 [TBL] [Abstract][Full Text] [Related]
10. A Saccharomyces boulardii-derived antioxidant protein, thioredoxin, ameliorates intestinal inflammation through transactivating epidermal growth factor receptor. Qin X; Zhao Q; Zhao Q; Yang L; Li W; Wu J; Liu T; Zhong W; Jiang K; Liu W; Wang B; Wang S; Cao H Pharmacol Res; 2024 Oct; 208():107372. PubMed ID: 39182661 [TBL] [Abstract][Full Text] [Related]
11. Long-term and continuous administration of Liu Y; Yin F; Huang L; Teng H; Shen T; Qin H Food Funct; 2021 Mar; 12(5):2201-2210. PubMed ID: 33595001 [TBL] [Abstract][Full Text] [Related]
12. [Effect of VSL#3 and Meng XC; Wang YN; Yan PG; Li YH; Wang HY; Qian JM; Li JN Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(22):1735-1742. PubMed ID: 31216822 [No Abstract] [Full Text] [Related]
13. Microbial hydrogen economy alleviates colitis by reprogramming colonocyte metabolism and reinforcing intestinal barrier. Ge L; Qi J; Shao B; Ruan Z; Ren Y; Sui S; Wu X; Sun X; Liu S; Li S; Xu C; Song W Gut Microbes; 2022; 14(1):2013764. PubMed ID: 35025709 [TBL] [Abstract][Full Text] [Related]
14. Effect of Mutant and Engineered High-Acetate-Producing Deleu S; Jacobs I; Vazquez Castellanos JF; Verstockt S; Trindade de Carvalho B; Subotić A; Verstockt B; Arnauts K; Deprez L; Vissers E; Lenfant M; Vandermeulen G; De Hertogh G; Verbeke K; Matteoli G; Huys GRB; Thevelein JM; Raes J; Vermeire S Nutrients; 2024 Aug; 16(16):. PubMed ID: 39203805 [TBL] [Abstract][Full Text] [Related]
15. Ketogenic diet aggravates colitis, impairs intestinal barrier and alters gut microbiota and metabolism in DSS-induced mice. Li S; Zhuge A; Wang K; Lv L; Bian X; Yang L; Xia J; Jiang X; Wu W; Wang S; Wang Q; Li L Food Funct; 2021 Oct; 12(20):10210-10225. PubMed ID: 34542110 [TBL] [Abstr